OBJECTIVE: Mutations in the human gene encoding the polyhormone peptide proopiomelanocortin (POMC) are associated with obesity in rare cases and the gene co-localizes with a reported quantitative trait loci (QTL) for variations in circulating leptin levels and fat mass on human chromosome 2p21. In this study we have used polymerase chain reaction (PCR) and single strand conformation polymorphism (SSCP) analysis, to test whether variations in the human POMC gene are associated with human obesity. DESIGN AND SUBJECTS: Primary mutational analysis was performed on the coding region of the POMC gene and 500 bp of the putative promoter region, by single strand conformational analysis and sequencing, in 56 subjects with juvenile onset obesity (body mass index (BMI) ! 31 kgam 2 at the draft board examination). The prevalence of two polymorphisms were further studied in 156 obese and 205 control subjects, and in a population based cohort of 380 extensively characterized young healthy subjects. RESULTS: We have identi®ed a total of six gene variants, ®ve were silent nucleotide substitutions (No51(promoter) g?c, No670(5 H UTR)g?a, No4512(codon6)c?t CysaCys, No7726(codon116)c?t LeuaLeu) of which one was prevalent (No8246(3 H UTR)c?t) and one variant changed an amino acid (No8086(codon236)g?c ArgaGln). The amino acid substitution was only seen in one subject. Comparing the prevalence of the frequent No8246 silent polymorphism, in an association study comprising 156 subjects with juvenile onset obesity and 205 randomly sampled control subjects (mean BMI 23.5 AE 4.7 kgam 2 ), did not show any relationship to obesity. Also, comparing the prevalence of a known 9 bp insertionadeletion variant in the coding region of the gene between obese and lean, showed no association to obesity. Furthermore, analyzing a population based cohort of 380 young healthy Caucasians for the prevalent 3
Introduction
Human obesity is a complex disorder determined by both inheritance and environment. Family studies 1 and studies of twins, 2, 3 as well as adoptees reared apart 4, 5, 6 show that from 30 ± 70% of the variation in adiposity is determined by genetic factors. However, little is known about the mode of inheritance and no gene variants responsible for the common form of human obesity has so far been identi®ed.
A recent study by Krude et al 7 has demonstrated that early onset severe obesity, adrenal insuf®ciency and red hair pigmentation, in two patients, is caused by mutations in the human proopiomelanocortin (POMC) gene. Moreover, a study by Comuzzie et al 8 has shown evidence of linkage between variations in circulating leptin concentrations and a locus on human chromosome 2p21. A weaker linkage was shown between the locus and measures of fat mass (FM). Among other candidate genes in the region, the POMC gene is located in the vicinity of this linkage region and is thus a candidate gene, potentially involved in the regulation of variations in serum leptin concentrations and obesity.
POMC is a polyhormone peptide, predominantly expressed in the brain, but also in the gut, placenta and pancreas. 9 The protein is processed and cleaved, in a tissue speci®c manner, into several smaller peptides, with distinct biological activities including melanocortins like adrenocorticotropin (ACTH) and a-, band g-melanocyte stimulating hormones (MSH). 10 Melanocortins are ligands for the melanocortin receptors (MC-R) of which there are ®ve isoforms, where MC2-R is the receptor for ACTH. 10 In the genetically obese agouti (A y ) mouse, ectopic overexpression of the Agouti protein, causes severe obesity, as well as yellow coloring of the skin. 11 In cell systems, the Agouti protein can antagonize the effect of a-MSH on the MC1-R and MC4-R.
Whereas mice lacking functional MC1-R, 14 or MC5-R, 15 are not obese, the targeted disruption of the MC4-R in mice causes obesity, very similar to the phenotype of the agouti obesity syndrome. 16 These ®ndings indicate that the antagonistic effect of agouti protein on the MC4-R, is involved in the etiology of the agouti obesity syndrome and further implicates the natural ligand a-MSH in the regulation of energy expenditure and food intake.
In the present study, we have analyzed the entire coding region of the POMC gene and 500 bp of the putative promoter region for mutations by single strand conformation analysis (SSCP), heteroduplex analysis and sequencing, in 56 male subjects with juvenile onset obesity. Furhermore, we have evaluated the frequency of polymorphic positions in the POMC gene in an association study of 156 obese and 205 control subjects, as well as in a population based sample of 380 healthy young Caucasians.
Subjects and methods
The obese study population consisted of young Danish men, who were examined at the draft board around the age of 20 y (range 18 ± 26 y), and who, in addition, had attended school in the Copenhagen municipality, where height and weight were measured as a part of the school health examinations. 17 The sample was further restricted to those who were examined at the Copenhagen City Heart Study Program in 1981 ± 1983 18 and again in 1992 ± 1994. The study group of men with juvenile onset obesity, was the 156 subjects who had a BMI ! 31 kgam 2 at the draft board examination. A control group of 205 draftees was selected at random as every hundredth from the same study population. This implies that the present study population encompasses approximately 20 500 subjects among whom the 156 obese subjects were identi®ed as the most obese, who participated in the study. Weight and height at different ages were recorded and BMI values at the ages of 7 y, 13 y and on average at the ages of 20 y, 37 y and 48 y are listed in Table 1 . Genomic DNA was obtained from blood samples, drawn at the last examination of the Copenhagen City Heart Study. A subgroup of 56 obese subjects were randomly selected from the obese group for the initial SSCP scanning.
The population based sample consisted of 184 men and 194 women, who were randomly recruited from a population of young individuals aged 18 ± 32 y, who in 1979a1980 and 1984a1985 participated in blood pressure surveys from a representative part of Copenhagen. All participants were extensively examined, and anthropometric and biochemical measures, as well as measures of insulin sensitivity, were recorded. The clinical and biochemical characteristics of the population have been presented previously. 19 Body fat content was estimated by a bioimpedance technique as described previously. 19, 20 Furthermore, fasting serum leptin concentrations were measured on all subjects as described below. The studies were approved by the Ethical Committee of Copenhagen and were in accordance with the principles of the declaration of Helsinki II.
Measurement of serum leptin
Serum leptin concentrations were measured using a human leptin radio immuno assay (RIA) kit (Linco, St Charles, MO). Serum samples of 100 ml were analyzed in duplicate for each subject, as described in the leptin RIA kit protocol. The interassay coef®cient of variation was`0.07.
DNA isolation
Genomic DNA was isolated by a modi®ed salt extraction method as described earlier. 21 
PCR-SSCP and heteroduplex analysis
Combined SSCP and heteroduplex analysis were performed on 56 subjects with juvenile onset obesity, randomly selected from the obese group. From the genomic sequence, primer pairs for polymerase chain reaction-SSCP (PCR-SSCP) speci®c to the genomic sequence of each exon were synthesized as shown in Table 2 . The primer and gene sequences were obtained from Genbank (Accession no.'s: V01510aK02406 and K00059). PCR-SSCP and heteroduplex formation analysis were performed at two different experimental settings, as described earlier. 21 
Mutation screening methods
The codon 236 Arg 3 Gln variant removes a recognition site for the restriction enzyme Hha I. Screening for this variant was performed by PCR, amplifying a segment using primers POMC6ab, and adding one unit of Hha I directly into the product, and after incubation, analyzing on a 3% agarose gel. Similarly, the codon Leu116Leu variant removes a recognition site for the restriction enzyme Msp AI in a PCR segment using primers POMC4ab, and this variant was detected by adding 1 unit of Msp AI enzyme to PCR ampli®ed segments, as described above. Screening for the 9 bp insertionadeletion variant at codons 94 or 97 was performed by PCR ampli®cation, using the primers listed in Table 2 (from Ref. 22), as described previously. 21 The ampli®ed segments were analyzed on a 5% agarose gel and stained with ethidium bromide. One sample of each allele was sequenced. The remaining variants were detected by SSCP and con®rmed by sequencing.
Statistical methods
Comparisons between groups were evaluated by Chi square test. Statistical Package of Social Science for Windows (SPSS), version 6.10, was used for statistical analysis. Box plots were generated with the SPSS software.
Results
The results of the PCR-SSCP and heteroduplex scanning of the POMC gene are listed in Table 3 and Table 4 , where nucleotide positions are numbered according to GenBank sequence accession number V01510. 22 in the translated region of exon 3. Three alleles of the repeat have been identi®ed with 1 (A1), 2 (A2) and 3 (A3) copies of the repeat. Genotyping the 205 control subjects and 156 obese subjects, revealed a prevalence of the respective alleles of A1: 0.0%, A2: 5.8% and A3: 94.2%, respectively in 156 obese and A1: 0.0%, A2: 3.4% and A3: 96.6%, respectively, in 205 control subjects as listed in Table 4 . Among 380 healthy young subjects, the prevalence of the respective alleles were A1: 0.5%, A2: 9.6% and A3: 89.9%. The Hardy-Weinberg distribution was normal for the two frequent polymorphisms (data not shown).
Study of the 3
H UTR variant in healthy young subjects
The prevalence of the common c ? t variant in the 3 H UTR region of the gene, as well as the 9 bp deletion, was further analyzed in a study of 380 young healthy Caucasians, consisting of 186 men and 194 women, on whom data of body fat percentage and fasting serum leptin levels were measured. However, we saw no association of either variant in heterozygous or homozygous form with deviations in body fat contents 
Discussion
A considerable number of studies indicate that genetic factors contribute to human obesity. Where the genetic defects underlying several monogenic forms of obesity in mice have been elucidated within recent years, little progress has been achieved regarding the genetic basis of the common forms of obesity in humans. 23 The recent study showing that mutations in the POMC gene may cause early onset severe obesity, 7 together with the studies implicating the POMC gene in the agouti mouse model, as well as linkage studies, 8, 12, 13 make this gene a relevant candidate for the inherited basis of human obesity.
In the present study, we have identi®ed six nucleotide substitutions in the gene, of which ®ve are rare variants. In the promoter region, a variant was found in two obese subjects in the heterozygous state. It is not localized to any region containing consensus in sequences of known transcription factors and no functional in¯uence of this variant could be predicted. However, although the variant is rare, it might still have an impact on the expression of the gene in the carriers. Expression studies of the cloned POMC promoter linked to reporter gene, are necessary to analyze the potential impact of this variant.
The variant in the 3 H UTR, at position 8246, is the only novel variant, prevalent enough to provide useful information in an association study of the present sample size. Although the variant is located outside the coding region, it may potentially in¯uence mRNA stability and thus speci®c protein levels or it could be in linkage dis-equilibrium with yet unidenti®ed gene variants. However, when we analyzed the entire group of 156 obese and 205 control subjects, this variant was not associated with obesity. Furthermore, in a population based study of 380 healthy young Caucasians, this variant did not show association to either body fat mass (FM) or fasting serum leptin concentrations, the phenotypes to which linkage was found in the Mexican-American population. 8 The Arg236Gln amino acid variant was only identi®ed in the heterozygous state in one obese subject out of 156 and in none of the 205 controls. The carrier of this variant did not differ signi®cantly in BMI from the mean of the cohort. However, this amino acid substitution is located at position 236 and the two codons 235 (Lys) and 236 (Arg) comprise a dibasic amino acid cleavage site, which is essential in the processing of several of the POMC-derived peptides. The Arg at this position is conserved in the POMC sequence from all other known organisms. The native b-LPH protein, which extends from position 178 to the C-terminal of the peptide, can be cleaved into the smaller g-LPH and a-, b,-and g-endorphin as well as metenkephalin peptides. 9 The processing of all of these peptides is dependent on the correct cleaving at the dibasic LysArg site, and thus this allele would not be expected to produce any of the b-LPH derived peptides. However, this prediction needs to be tested by expression studies in cell lines that express PC1 and PC2, the proteases thought to be responsible for the processing of POMC. Also the biological implication of this allele in the heterozygous state needs to be further examined. It could be hypothesized that the lack of processing of the mutant allele is compensated by transcriptional upregulation of the non-mutated allele. However, as the POMC protein is a polyhormone, this would also mean upregulation of the expression of N-terminal derived peptides to supernormal levels. From the presently available data, the subjects presented as normal, apart from the obese phenotype. Test for segregation of this variant with obesity or related phenotypes is warranted.
From previous studies, a cryptic trinucleotide repeat was identi®ed. 22, 24 In the present study we have detected two of the previously identi®ed alleles with one (A2) and two (A3) copies of the 9 bp repeat, respectively. However, the allele frequencies are very different compared to one study, 22 which could be due to differences in ethnic background between the two populations. In our study neither of the alleles were associated with obesity, body fat contents or fasting serum leptin concentrations.
POMC may be potentially implicated in the etiology of several monogenic forms of obesity. Apart from a possible in¯uence of the Agouti protein on a-MSH binding in the agouti (A y ) mouse, 12 the genetically obese carboxypeptidase E de®cient fatafat mouse 25 shows defective processing of insulin, but could also be in¯uenced by the incomplete processing of POMC peptides. Furthermore, a recent study by Jackson et al 26 has shown an association for human obesity with a defect in the gene encoding PC1, which is known to process POMC peptides. These ®ndings, together with the very recent identi®cation of obesitycausing mutations in the POMC gene in two human subjects, demonstrate that the products of the POMC gene have in¯uence on body weight control. However, in the present study we failed to identify genetic variations in¯uencing obesity in our cohorts. Whereas there could be yet unidenti®ed variants in the POMC gene affecting obesity, it is also possible, that the obesity causing effect of POMC is restricted to rare cases of severe obesity. We conclude that it is unlikely that genetic variations in the putative promoter and the coding region of the POMC gene is a common cause of early onset obesity in Caucasian men.
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